Literature DB >> 18951442

A database to support the interpretation of human mismatch repair gene variants.

Jianghua Ou1, Renée C Niessen, Jan Vonk, Helga Westers, Robert M W Hofstra, Rolf H Sijmons.   

Abstract

Germline mutations in the mismatch repair (MMR) genes MLH1, MSH2, MSH6, or PMS2 can cause Lynch syndrome. This syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominantly-inherited disorder predominantly characterized by colorectal and endometrial cancer. Truncating MMR gene mutations generally offer a clear handle for genetic counseling and allow for presymptomatic testing. In contrast, the clinical implications of most missense mutations and small in-frame deletions detected in patients suspected of having Lynch syndrome are unclear. We have constructed an online database, the Mismatch Repair Gene Unclassified Variants Database (www.mmruv.info), for information on the results of functional assays and other findings that may help in classifying these MMR gene variants. Ideally, such mutations should be clinically classified by a broad expert panel rather than by the individual database curators. In addition, the different MMR gene mutation databases could be interlinked or combined to increase user-friendliness and avoid unnecessary overlap between them. Both activities are presently being organized by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT; www.insight-group.org). (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951442     DOI: 10.1002/humu.20907

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  27 in total

1.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

Review 2.  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome.

Authors:  Michael P Farrell; David J Hughes; Ian R Berry; David J Gallagher; Emily A Glogowski; Stewart J Payne; Michael J Kennedy; Róisín M Clarke; Susan A White; Cian B Muldoon; Fiona Macdonald; Pauline Rehal; Danielle Crompton; Solvig Roring; Sarah T Duke; Trudi McDevitt; David E Barton; Shirley V Hodgson; Andrew J Green; Peter A Daly
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.

Authors:  M P Farrell; D J Hughes; M Drost; A J Wallace; R J Cummins; T A Fletcher; M A Meany; E W Kay; N de Wind; D G Power; E J Andrews; A J Green; D J Gallagher
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

4.  Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.

Authors:  Mev Dominguez Valentin; Felipe Carneiro da Silva; Erika Maria Monteiro dos Santos; Bianca Garcia Lisboa; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Israel Gomy; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mariana Redal; Carlos Vaccaro; Adriana Della Valle; Carlos Sarroca; Dirce Maria Carraro; Benedito Mauro Rossi
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

5.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

Review 6.  Next generation sequencing and a new era of medicine.

Authors:  Graham Casey; David Conti; Robert Haile; David Duggan
Journal:  Gut       Date:  2012-05-01       Impact factor: 23.059

7.  Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.

Authors:  Sean V Tavtigian; Marc S Greenblatt; David E Goldgar; Paolo Boffetta
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.

Authors:  Adam S Mastrocola; Christopher D Heinen
Journal:  Hum Mutat       Date:  2010-10       Impact factor: 4.878

9.  The InSiGHT database: utilizing 100 years of insights into Lynch syndrome.

Authors:  J P Plazzer; R H Sijmons; M O Woods; P Peltomäki; B Thompson; J T Den Dunnen; F Macrae
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 10.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.